DRKS00013765.
Methods | Study design: RCT Study grouping: parallel group Unit of randomisation: individuals Power (power & sample size calculation, level of power achieved): not specified in trial registration Imputation of missing data: not specified |
Participants |
Country: Germany, Austria, Switzerland
Setting: online intervention
Age: not specified
Sample size (randomised): 260 targeted
Sex: not specified
Comorbidity (mean (SD) of respective measures in indicated, if available): not specified
Population description: resilient college students
Inclusion criteria: 1) student status; 2) internet access; 3) consent; 4) sex: both; 5) age: no minimum or maximum age limit
Exclusion criteria: 1) individuals with significant minor resilience (1 SD below average); 2) individuals who have been diagnosed with a mental disorder within the past 12 months; 3) individuals who are on a waiting list for a psychotherapy, are currently in treatment or have experienced psychotherapeutic treatment in the last 12 months; 4) current or lifelong psychotic or bipolar disorder; 5) individuals with high suicide risk Attrition (withdrawals and exclusions): not specified Reasons for missing data: not specified |
Interventions |
Intervention: StudiCare: Resilienz UP (n randomised not specified)
Control: wait‐list control (n randomised not specified)
|
Outcomes |
Outcomes collected and reported: Primary outcome:
Secondary outcomes:
Outcomes reported not specified Time points measured and reported: post‐intervention (8 weeks after randomisation); time points reported not specified Adverse events: not specified |
Notes |
Contact with authors: We contacted the authors to ask whether the trial also included healthcare students, but received no response Study start/end date: date of first enrolment: 15 March 2018; end date not specified Funding source: primary sponsor: BARMER GEK (Hauptverwaltung, Produktentwicklung, Versorgungsmanagement, Prävention); European Union Declaration of interest: not specified Ethical approval needed/obtained for study: approved by Ethics Committee of Friedrich‐Alexander‐University Erlangen‐Nürnberg Comments by study authors: website, studicare.com Miscellaneous outcomes by the review authors: based on trial registration, recruiting; unclear if trial also includes healthcare students Correspondence: Dr Daniel Ebert, Nägelsbachstraße 25a, 91052 Erlangen, Germany; Daniel.Eber@fau.de; phone +49 9131 8567567 |